Gliomas are the most common of the primary brain tumors and account for more than 40% of all central nervous system neoplasms. Gliomas include tumours that are composed predominantly of astrocytes (astrocytomas), oligodendrocytes (oligodendrogliomas), mixtures of various glial cells (for example,oligoastrocytomas) and ependymal cells (ependymomas). The most malignant form of infiltrating astrocytoma - glioblastoma multiforme (GBM) - is one of the most aggressive human cancers. GBM may develop de novo (primary glioblastoma) or by progression from low-grade or anaplastic astrocytoma (secondary glioblastoma). Primary glioblastomas develop in older patients and typically show genetic alterations (EGFR amplification, p16/INK4a deletion, and PTEN mutations) at frequencies of 24-34%. Secondary glioblastomas develop in younger patients and frequently show overexpression of PDGF and CDK4 as well as p53 mutations (65%) and loss of Rb playing major roles in such transformations. Loss of PTEN has been implicated in both pathways, although it is much more common in the pathogenesis of primary GBM.

Human Diseases; Cancer: specific types
BRITE hierarchy

Nannospalax galili (Upper Galilee mountains blind mole rat) [GN:ngi]

PMID:15639402

Soni D, King JA, Kaye AH, Hovens CM.

Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.

J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001

PMID:12154354

Zhu Y, Parada LF.

The molecular and genetic basis of neurological tumours.

Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866

PMID:11253051

Holland EC.

Gliomagenesis: genetic alterations and mouse models.

Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535

PMID:16700615

Bansal K, Liang ML, Rutka JT.

Molecular biology of human gliomas.

Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302

(Japanese)

Tabuchi K (ed).

[Gliomas: Research and therapy] (In Japanese)

Springer-Verlag Tokyo (2006)

PMID:12762887

Kapoor GS, O'Rourke DM.

Mitogenic signaling cascades in glial tumors.

Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39

PMID:16095998

Hulleman E, Helin K.

Molecular mechanisms in gliomagenesis.

Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3

PMID:11057895

Schlessinger J.

Cell signaling by receptor tyrosine kinases.

Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8

PMID:9643506

Ng HK, Lam PY.

The molecular genetics of central nervous system tumors.

Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236

PMID:12084351

Knobbe CB, Merlo A, Reifenberger G.

Pten signaling in gliomas.

Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196